Literature DB >> 31380231

Metoidioplasty: techniques and outcomes.

Miroslav L Djordjevic1, Borko Stojanovic1, Marta Bizic1.   

Abstract

Phalloplasty represents the latest step in female-to-male transitioning and still remains a great challenge for transgender surgeons. Since we have two options in this transitioning-metoidioplasty and total phalloplasty-the transgender surgeon has to fully inform the individual about all aspects such as surgical steps, outcomes, advantages and disadvantages, possible complications, and expectations. Total phalloplasty with the creation of a neophallus of a similar volume to that in genetic males, is a complex and multi-staged procedure. Many different tissues (i.e., flaps) can be used, and the ideal procedure is still not established. In contrast to the above complexities involved in total phalloplasty, metoidioplasty presents a simple and one-stage procedure for the creation of a neophallus from a hormonally enlarged clitoris. This technique is very promising for individuals who desire gender-affirmation surgery without having to undergo the difficult and multistage creation of a male-sized neophallus. Also, this technique prevents scarring to the extragenital region, making the final results more acceptable for transgender individuals. Our goal is to objectively present the techniques for metoidioplasty and to define their value based on postoperative results.

Entities:  

Keywords:  Clitoris; female transgender; gender-affirming surgery; metoidioplasty; outcomes

Year:  2019        PMID: 31380231      PMCID: PMC6626308          DOI: 10.21037/tau.2019.06.12

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  8 in total

1.  The Sexual Goals of Metoidioplasty Patients and Their Attitudes Toward Using PDE5 Inhibitors and Intracavernosal Injections as Erectile Aids.

Authors:  Amir Khorrami; Sahil Kumar; Elise Bertin; Richard Wassersug; Cormac O'Dwyer; Smita Mukherjee; Luke Witherspoon; Peter Mankowski; Krista Genoway; Alex G Kavanagh
Journal:  Sex Med       Date:  2022-04-08       Impact factor: 2.523

2.  'Modified Phallourethroplasty' as a Surgical Alternative to Phalloplasty With Urethral Lengthening: Technique, How We Present This Option to Patients, and Clinical Outcomes.

Authors:  Shannon M Smith; Nance Yuan; Grace Lee; Jenna Stelmar; Edward Ray; Maurice M Garcia
Journal:  Sex Med       Date:  2022-03-04       Impact factor: 2.523

Review 3.  Imaging in Gender Affirmation Surgery.

Authors:  Omar Hassan; Derek Sun; Priyanka Jha
Journal:  Curr Urol Rep       Date:  2021-01-30       Impact factor: 3.092

Review 4.  ESSM Position Statement "Sexual Wellbeing After Gender Affirming Surgery".

Authors:  Müjde Özer; Sahaand Poor Toulabi; Alessandra D Fisher; Guy T'Sjoen; Marlon E Buncamper; Stan Monstrey; Marta R Bizic; Miroslav Djordjevic; Marco Falcone; Nim A Christopher; Daniel Simon; Luis Capitán; Joz Motmans
Journal:  Sex Med       Date:  2021-12-28       Impact factor: 2.491

Review 5.  Metoidioplasty in Gender Affirmation: A Review.

Authors:  Borko Stojanovic; Marko Bencic; Marta Bizic; Miroslav L Djordjevic
Journal:  Indian J Plast Surg       Date:  2022-06-24

6.  Feasibility, Safety, and Satisfaction of Combined Hysterectomy with Bilateral Salpingo-Oophorectomy and Chest Surgery in Transgender and Gender Non-Conforming Individuals.

Authors:  Ilaria Mancini; Davide Tarditi; Giulia Gava; Stefania Alvisi; Luca Contu; Paolo Giovanni Morselli; Giulia Giacomelli; Alessandra Lami; Renato Seracchioli; Maria Cristina Meriggiola
Journal:  Int J Environ Res Public Health       Date:  2021-07-03       Impact factor: 3.390

7.  Metoidioplasty: Surgical Options and Outcomes in 813 Cases.

Authors:  Noemi Bordas; Borko Stojanovic; Marta Bizic; Arpad Szanto; Miroslav L Djordjevic
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-13       Impact factor: 5.555

Review 8.  Masculinizing genital gender-affirming surgery: metoidioplasty and urethral lengthening.

Authors:  Ervin Kocjancic; Omer Acar; Susan Talamini; Loren Schechter
Journal:  Int J Impot Res       Date:  2020-03-19       Impact factor: 2.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.